ELTX earnings: next report 2026-08-06, real EPS beat/miss history, analyst consensus Hold, P/E -1.32. Updated 2026-07-23.
Elicio Therapeutics (ELTX) Research Hub
Elicio Therapeutics (ELTX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 2.05 USD (-5.96%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.32, market cap 0.06B. This hub links to the full technical, earnings and options research available for ELTX.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 2.05 USD (-5.96%) |
| 52-week range | 2.025 USD – 6.64 USD |
| Trend regime | Range |
| 14-day RSI | 14.4 (Oversold) |
| Trailing P/E | -1.32 |
| Market cap | 0.06B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-06 |
Available research for ELTX
Covered Call on ELTX: how it works, illustrative setup around the real 2.05 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ELTX: how it works, illustrative setup around the real 2.05 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ELTX: how it works, illustrative setup around the real 2.05 USD price, max profit/loss, breakeven and when to use it. Educational.
ELTX technical analysis: range, last 2.05 USD, RSI 14.4, 52w range 2.025 USD–6.64 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is ELTX in?
Elicio Therapeutics (ELTX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ELTX in an uptrend or downtrend?
As of 2026-09-11, ELTX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ELTX's trailing P/E ratio?
ELTX's trailing P/E is -1.32, with a market cap of 0.06B. See the earnings research page for full valuation detail.
When does ELTX next report earnings?
ELTX is next scheduled to report earnings on 2026-08-06, with a consensus EPS estimate of -0.53 USD.